Inombolo yeCas: 168273-06-1 Ifomula yeMolekyuli:C22H21Cl3N4O
Indawo yokunyibilika | 154.7 °C |
Ukuxinana | 1.299 |
ixesha lokugcina | akukho zithintelo. |
ukunyibilika | I-Soluble kwi-DMSO (ukuya kwi-20 mg / ml) okanye kwi-Ethanol (ukuya kwi-20 mg / ml).idimethyl sulfoxide kwaye ayinyibiliki kwibenzene okanye ihexane. |
umsebenzi wamehlo | N / A |
Imbonakalo | mhlophe ukuya kokukhanya kwekristale powde emthubi |
Ubunyulu | ≥98% |
ngumchasi ochasene ne-cannabinoid receptor (CB1).Isebenza ngokuthintela ngokukhethekileyo i-CB1 i-receptors efunyenwe kwingqondo nakwizitho ezithintekayo ezibalulekileyo kwi-glucose kunye ne-lipid metabolism, kuquka izicubu ze-adipose, isibindi, i-gastrointestinal tract, kunye nemisipha.Ke, ibandakanya indlela yonyango yokutyeba kakhulu kunye nezinto ezinobungozi bentliziyo.Njengeziyobisi ezichasene ne-anorectic antiobesity, yayisetyenziswe njengenxalenye yokutya kunye nokuzilolonga kwizigulane ezityebileyo okanye ezigqithiseleyo kunye nezinto ezinobungozi ezinxulumene neYurophu kwi-2006. Nangona kunjalo, iziphumo ezibi ezibandakanya ukuzibulala, ukudakumba, kunye nokuxhalaba zaxelwa, ngokusekelwe apho i-rimonadant ihoxisiwe. kwihlabathi liphela ngo-2008.
I-Andogenous cannabinoids inxulumene nesiphumo esithandekayo se-nicotine, njenge-cannabinoid receptor blocker, iphinda ivavanywe njengonyango oluchasene nokutshaya.
yi-immunomodulatory CB1 receptor inverse agonist
Cela uGqirha acebise kuqala